pancan.ai/Ask
what is known about trial:nct:NCT07438106
Understood asRecord NCT07438106View getStudy → table
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer NCT07438106↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.